0

Autoimmune Disease Diagnostics Market by Product, Type, and Geography - Forecast and Analysis 2021-2025

  • Published: Jun 2021
  • Pages: 120
  • SKU: IRTNTR41431
Technavio

Enjoy complimentary customisation on priority with our Enterprise License!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted

info
close
  • Single User:

    Quick and easy buy and download option

  • Enterprise:

    Flexible option - Complimentary customization included

2500 USD

The autoimmune disease diagnostics market share is expected to increase by USD 1.98 billion from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 9%.

This autoimmune disease diagnostics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers autoimmune disease diagnostics market segmentations by product (assay kits and analyzers), type (localized autoimmune disease diagnostics and systemic autoimmune disease diagnostics), and geography (North America, Europe, APAC, South America). The autoimmune disease diagnostics market report also offers information on several market vendors, including Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hemagen Diagnostics Inc., HOB Biotech Group Corp., Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc. among others.

What will the Autoimmune Disease Diagnostics Market Size be During the Forecast Period?

Autoimmune Disease Diagnostics Market Size

Download the Free Report Sample to Unlock the Autoimmune Disease Diagnostics Market Size for the Forecast Period and Other Important Statistics

 

Autoimmune Disease Diagnostics Market: Key Drivers, Trends, and Challenges

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The discovery of novel biomarkers leading to an improved autoimmune diagnosis is notably driving the autoimmune disease diagnostics market growth, although factors such as limitations of autoimmune disease diagnostics may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the autoimmune disease diagnostics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Autoimmune Disease Diagnostics Market Driver

The discovery of novel biomarkers leading to an improved autoimmune diagnosis is a major factor driving the global autoimmune disease diagnostics market share growth. The development of novel biomarkers has resulted in the improvement in the diagnosis of autoimmune diseases. Individuals with autoimmune diseases can develop multiple symptoms, which can be tough for physicians to diagnose. The use of singular conventional biomarkers proved to be of little help and limited reproducibility for laboratory personnel. Therefore, there is an increased demand for multiple biomarkers that could help identify and evaluate the patient status, disease type, and progression, and response to therapy for autoimmune diseases. Also, the development of autoantibodies to a given protein is witnessed only in a limited number of individuals affected by the disease. Thus, vendors and research institutes are conducting exhaustive R&D activities and are posting promising results in the use of multiple biomarkers for the diagnosis of autoimmune diseases. The ability to screen an individual with multiple biomarkers associated with several autoimmune diseases has improved the positive diagnosis. Moreover, it has substantially influenced the global autoimmune disease diagnostics market and would continue to prove to be an added advantage for physicians in the diagnosis of such complications.

Key Autoimmune Disease Diagnostics Market Trend

The focus on companion diagnostic tests is another factor supporting the global autoimmune disease diagnostics market share growth. Companion diagnostics allow the screening of individuals or groups who are likely to respond better to a therapeutic agent. The advances in companion diagnostic test for an autoimmune disease involves the use of a diagnostic test and monitoring of disease prognosis in individuals undergoing therapy. The test offers insights into the therapeutic regimen's positive impact on these people about the reduction in the intensity of autoimmune diseases. Many vendors in the market are focusing on developing companion diagnostic tests for autoimmune diseases. For instance, as of June 2019, a startup based in Buffalo, US, was focusing on developing tests that were compatible with the AESKU Diagnostics Helios system. Companies partnered with UB's Buffalo Institute for Genomics and Data Analytics to gain access to biomedical, genomics, and big data expertise to develop new technologies in various fields, including companion diagnostics systems. Therefore, the market will continue to grow during the forecast period.

Key Autoimmune Disease Diagnostics Market Challenge

The limitations of autoimmune disease diagnostics will be a major challenge for the global autoimmune disease diagnostics market share growth during the forecast period. The limitation in autoimmune disease diagnostics regarding key parameters such as accuracy poses a challenge to the market. For instance, the accuracy of autoimmune disease diagnostics determines the quality of results. Any discrepancy in this parameter will be unproductive to end-users, thereby increasing the chances to impact the adoption rates. In the market, there are only a few tests that can potentially offer quality results. These tests allow rapid decision-making and administration of suitable therapy for treating individuals with autoimmune diseases. Inaccuracy in results during the diagnosis of some high-risk autoimmune diseases will result in various complications. It can also compromise the brand equity of vendors. For instance, granulomatosis with polyangiitis is an autoimmune disease that can be life-threatening if the associated diagnosis is not rapid and precise. This can negatively impact the adoption of autoimmune disease testing kits among hospitals and research laboratories, thereby hampering the growth of the market.

This autoimmune disease diagnostics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

Parent Market Analysis

Technavio categorizes the global autoimmune disease diagnostics market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the autoimmune disease diagnostics market during the forecast period.

Who are the Major Autoimmune Disease Diagnostics Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

  • Abbott Laboratories
  • bioMérieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hemagen Diagnostics Inc.
  • HOB Biotech Group Corp.
  • Quest Diagnostics Inc.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

This statistical study of the autoimmune disease diagnostics market encompasses successful business strategies deployed by the key vendors. The autoimmune disease diagnostics market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.

Product Insights and News

  • Abbott Laboratories- The ARCHITECT i2000SR immunoassay analyzer offers a maximum throughput of up to 200 tests per hour. I tis featuring with a load-up capacity of 135 samples with 35 priority and 100 routine areas, the ARCHITECT i2000SR has 25 refrigerated reagent positions.

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The autoimmune disease diagnostics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Autoimmune Disease Diagnostics Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the autoimmune disease diagnostics market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

The value chain of global healthcare equipment market includes the following core components:

  • Inputs
  • Inbound logistics
  • Operations
  • Outbound logistics
  • Marketing and sales
  • Service
  • Support activities
  • Innovation

The report has further elucidated on other innovative approaches being followed by manufacturers to ensure a sustainable market presence.

Which are the Key Regions for Autoimmune Disease Diagnostics Market?

Autoimmune Disease Diagnostics Market Market segmentation by region

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for autoimmune disease diagnostics market in North America. Market growth in this region will be slower than the growth of the market in APAC.

Discovery of novel biomarkers leading to improved autoimmune diagnosis will facilitate the autoimmune disease diagnostics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

What are the Revenue-generating Product Segments in the Autoimmune Disease Diagnostics Market?

Autoimmune Disease Diagnostics Market Segmentation

To gain further insights on the market contribution of various segments Request for a FREE sample

The autoimmune disease diagnostics market share growth by the assay kits segment will be significant during the forecast period. The development of these products is increasing due to the availability of grants for quarterly reimbursements by the NIH on their R&D. The presence of higher gross margins from assay kits has led many vendors to focus on them rather than instruments. Vendors that develop instruments with a broad brand recognition focus on manufacturing closed systems as these are a one-stop solution. Further, the increasing incidence of autoimmune disorders has fuelled the need for new assay kits.

This report provides an accurate prediction of the contribution of all the segments to the growth of the autoimmune disease diagnostics market size and actionable market insights on post COVID-19 impact on each segment.

 

Autoimmune Disease Diagnostics Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 9%

Market growth 2021-2025

$ 1.98 billion

Market structure

Fragmented

YoY growth (%)

8.50

Regional analysis

North America, Europe, APAC, South America

Performing market contribution

North America at 42%

Key consumer countries

US, UK, Germany, Canada, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hemagen Diagnostics Inc., HOB Biotech Group Corp., Quest Diagnostics Inc., Siemens AG, and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Autoimmune Disease Diagnostics Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive autoimmune disease diagnostics market growth during the next five years
  • Precise estimation of the autoimmune disease diagnostics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the autoimmune disease diagnostics industry across North America, Europe, APAC, South America
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of autoimmune disease diagnostics market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 01: Parent market
    • Exhibit 02: Market characteristics
  • 2.2 Value chain analysis
    • Exhibit 03: Value Chain Analysis: Healthcare Equipment Market

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 04: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 05: Market segments
  • 3.3 Market size 2020
    • 3.4 Market outlook: Forecast for 2020 - 2025
      • Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
      • Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 08: Five forces analysis 2020 & 2025
    • 4.2 Bargaining power of buyers
      • Exhibit 09: Bargaining power of buyers
    • 4.3 Bargaining power of suppliers
      • Exhibit 10: Bargaining power of suppliers
    • 4.4 Threat of new entrants
      • Exhibit 11: Threat of new entrants
    • 4.5 Threat of substitutes
      • Exhibit 12: Threat of substitutes
    • 4.6 Threat of rivalry
      • Exhibit 13: Threat of rivalry
    • 4.7 Market condition
      • Exhibit 14: Market condition - Five forces 2020

    5 Market Segmentation by Product

    • 5.1 Market segments
      • Exhibit 15: Product - Market share 2020-2025 (%)
    • 5.2 Comparison by Product
      • Exhibit 16: Comparison by Product
    • 5.3 Assay kits - Market size and forecast 2020-2025
      • Exhibit 17: Assay kits - Market size and forecast 2020-2025 ($ million)
      • Exhibit 18: Assay kits - Year-over-year growth 2020-2025 (%)
    • 5.4 Analyzers - Market size and forecast 2020-2025
      • Exhibit 19: Analyzers - Market size and forecast 2020-2025 ($ million)
      • Exhibit 20: Analyzers - Year-over-year growth 2020-2025 (%)
    • 5.5 Market opportunity by Product
      • Exhibit 21: Market opportunity by Product

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 22: Type - Market share 2020-2025 (%)
    • 6.2 Comparison by Type
      • Exhibit 23: Comparison by Type
    • 6.3 Localized autoimmune disease diagnostics - Market size and forecast 2020-2025
      • Exhibit 24: Localized autoimmune disease diagnostics - Market size and forecast 2020-2025 ($ million)
      • Exhibit 25: Localized autoimmune disease diagnostics - Year-over-year growth 2020-2025 (%)
    • 6.4 Systemic autoimmune disease diagnostics - Market size and forecast 2020-2025
      • Exhibit 26: Systemic autoimmune disease diagnostics - Market size and forecast 2020-2025 ($ million)
      • Exhibit 27: Systemic autoimmune disease diagnostics - Year-over-year growth 2020-2025 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 28: Market opportunity by Type

    7 Customer landscape

    8 Geographic Landscape

    • 8.1 Geographic segmentation
      • Exhibit 30: Market share by geography 2020-2025 (%)
    • 8.2 Geographic comparison
      • Exhibit 31: Geographic comparison
    • 8.3 North America - Market size and forecast 2020-2025
      • Exhibit 32: North America - Market size and forecast 2020-2025 ($ million)
      • Exhibit 33: North America - Year-over-year growth 2020-2025 (%)
    • 8.4 Europe - Market size and forecast 2020-2025
      • Exhibit 34: Europe - Market size and forecast 2020-2025 ($ million)
      • Exhibit 35: Europe - Year-over-year growth 2020-2025 (%)
    • 8.5 Asia - Market size and forecast 2020-2025
      • Exhibit 36: Asia - Market size and forecast 2020-2025 ($ million)
      • Exhibit 37: Asia - Year-over-year growth 2020-2025 (%)
    • 8.6 ROW - Market size and forecast 2020-2025
      • Exhibit 38: ROW - Market size and forecast 2020-2025 ($ million)
      • Exhibit 39: ROW - Year-over-year growth 2020-2025 (%)
    • 8.7 Key leading countries
      • Exhibit 40: Key leading countries
    • 8.8 Market opportunity by geography
      • Exhibit 41: Market opportunity by geography ($ million)

    9 Drivers, Challenges, and Trends

    • 9.1 Market drivers
      • 9.2 Market challenges
        • Exhibit 42: Impact of drivers and challenges
      • 9.3 Market trends

        10 Vendor Landscape

        • 10.1 Overview
          • 10.2 Vendor landscape
            • Exhibit 43: Vendor landscape
          • 10.3 Landscape disruption
            • Exhibit 44: Landscape disruption
            • Exhibit 45: Industry risks

          11 Vendor Analysis

          • 11.1 Vendors covered
            • Exhibit 46: Vendors covered
          • 11.2 Market positioning of vendors
            • Exhibit 47: Market positioning of vendors
          • 11.3 Abbott Laboratories
            • Exhibit 48: Abbott Laboratories - Overview
            • Exhibit 49: Abbott Laboratories - Business segments
            • Exhibit 50: Abbott Laboratories - Key news
            • Exhibit 51: Abbott Laboratories - Key offerings
            • Exhibit 52: Abbott Laboratories - Segment focus
          • 11.4 bioMerieux SA
            • Exhibit 53: bioMerieux SA - Overview
            • Exhibit 54: bioMerieux SA - Business segments
            • Exhibit 55: bioMerieux SA - Key news
            • Exhibit 56: bioMerieux SA - Key offerings
            • Exhibit 57: bioMerieux SA - Segment focus
          • 11.5 Bio-Rad Laboratories Inc.
            • Exhibit 58: Bio-Rad Laboratories Inc. - Overview
            • Exhibit 59: Bio-Rad Laboratories Inc. - Business segments
            • Exhibit 60: Bio-Rad Laboratories Inc.-Key news
            • Exhibit 61: Bio-Rad Laboratories Inc. - Key offerings
            • Exhibit 62: Bio-Rad Laboratories Inc. - Segment focus
          • 11.6 Danaher Corp.
            • Exhibit 63: Danaher Corp. - Overview
            • Exhibit 64: Danaher Corp. - Business segments
            • Exhibit 65: Danaher Corp. -Key news
            • Exhibit 66: Danaher Corp. - Key offerings
            • Exhibit 67: Danaher Corp. - Segment focus
          • 11.7 F. Hoffmann-La Roche Ltd.
            • Exhibit 68: F. Hoffmann-La Roche Ltd. - Overview
            • Exhibit 69: F. Hoffmann-La Roche Ltd. - Business segments
            • Exhibit 70: F. Hoffmann-La Roche Ltd.- Key news
            • Exhibit 71: F. Hoffmann-La Roche Ltd. - Key offerings
            • Exhibit 72: F. Hoffmann-La Roche Ltd. - Segment focus
          • 11.8 Hemagen Diagnostics Inc.
            • Exhibit 73: Hemagen Diagnostics Inc. - Overview
            • Exhibit 74: Hemagen Diagnostics Inc. - Product and service
            • Exhibit 75: Hemagen Diagnostics Inc. - Key offerings
          • 11.9 HOB Biotech Group Corp.
            • Exhibit 76: HOB Biotech Group Corp. - Overview
            • Exhibit 77: HOB Biotech Group Corp. - Product and service
            • Exhibit 78: HOB Biotech Group Corp. - Key offerings
          • 11.10 Quest Diagnostics Inc.
            • Exhibit 79: Quest Diagnostics Inc. - Overview
            • Exhibit 80: Quest Diagnostics Inc. - Business segments
            • Exhibit 81: Quest Diagnostics Inc. - Key news
            • Exhibit 82: Quest Diagnostics Inc. - Key offerings
            • Exhibit 83: Quest Diagnostics Inc. - Segment focus
          • 11.11 Siemens AG
            • Exhibit 84: Siemens AG - Overview
            • Exhibit 85: Siemens AG - Business segments
            • Exhibit 86: Siemens AG -Key news
            • Exhibit 87: Siemens AG - Key offerings
            • Exhibit 88: Siemens AG - Segment focus
          • 11.12 Thermo Fisher Scientific Inc.
            • Exhibit 89: Thermo Fisher Scientific Inc. - Overview
            • Exhibit 90: Thermo Fisher Scientific Inc. - Business segments
            • Exhibit 91: Thermo Fisher Scientific Inc.- Key news
            • Exhibit 92: Thermo Fisher Scientific Inc. - Key offerings
            • Exhibit 93: Thermo Fisher Scientific Inc. - Segment focus

          12 Appendix

          • 12.1 Scope of the report
            • 12.2 Currency conversion rates for US$
              • Exhibit 94: Currency conversion rates for US$
            • 12.3 Research methodology
              • Exhibit 95: Research Methodology
              • Exhibit 96: Validation techniques employed for market sizing
              • Exhibit 97: Information sources
            • 12.4 List of abbreviations
              • Exhibit 98: List of abbreviations

            Research Framework

            Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

            TechnavioINFORMATION SOURCES

            Primary sources

            • Manufacturers and suppliers
            • Channel partners
            • Industry experts
            • Strategic decision makers

            Secondary sources

            • Industry journals and periodicals
            • Government data
            • Financial reports of key industry players
            • Historical data
            • Press releases
            Technavio

            TechnavioDATA ANALYSIS

            Data Synthesis

            • Collation of data
            • Estimation of key figures
            • Analysis of derived insights

            Data Validation

            • Triangulation with data models
            • Reference against proprietary databases
            • Corroboration with industry experts
            Technavio

            TechnavioREPORT WRITING

            Qualitative

            • Market drivers
            • Market challenges
            • Market trends
            • Five forces analysis

            Quantitative

            • Market size and forecast
            • Market segmentation
            • Geographical insights
            • Competitive landscape
            Interested in this report?
            Get your sample now!
            Autoimmune Disease Diagnostics Market market growth will increase by $1.98 bn during 2021-2025.
            The autoimmune disease diagnostics market market is expected to grow at a CAGR of 9% during 2021-2025.
            Technavio has segmented the autoimmune disease diagnostics market market by product (assay kits and analyzers) ,type (localized autoimmune disease diagnostics, systemic autoimmune disease diagnostics, Material sciences, and Nanotechnology) , and geography (North America, Europe, APAC, South America, and North America).
            Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hemagen Diagnostics Inc., HOB Biotech Group Corp., Quest Diagnostics Inc., Siemens AG, Thermo Fisher Scientific Inc. are a few of the key vendors in the autoimmune disease diagnostics market market.
            North America will register the highest growth rate of 42% among the other regions. Therefore, the autoimmune disease diagnostics market market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
            The key factors driving the autoimmune disease diagnostics market market growth are:
            • Discovery of novel biomarkers leading to an improved autoimmune diagnosis
            • Focus on companion diagnostic tests
            The autoimmune disease diagnostics market market vendors should focus on grabbing business opportunities from the assay kits segment as it accounted for the largest market share in the base year.
            • What are the key global market and the regional market share?
            • What are the revenue-generating key market segments?
            • What are the key factors driving and challenging this market’s growth?
            • Who are the key market vendors and their growth strategies?
            • What are the latest trends influencing the growth of this market?
            • What are the variables influencing the market growth in the primary regions?
            • What are the factors influencing the growth of the parent market?
            • Off-the-shelf research reports
            • Reports can be tailored to meet the customer's needs
            • Trusted by more than 100 fortune 500 organizations
            • Information about the market's key drivers, trends, and challenges
            • Parent market analysis
            • Every week, 50,000 people visit our subscription platform
            • Detailed vendors report with competitive landscape
            • Covid-19 impact and recovery analysis
            • Data on revenue-generating market segments
            • Details on the market shares of various regions
            • Five-force market analysis

            Certified ISO 9001 : 2015

            We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

            We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

            Safe and Secure SSL Encrypted
            Technavio

            info
            close
            • Single User:

              Quick and easy buy and download option

            • Enterprise:

              Flexible option - Complimentary customization included

            2500 USD

            Technavio Get the report (PDF) sent to your email within minutes.

            Subscribe & Save

            Get lifetime access to our
            Technavio Insights

            Customized Report as per your Business Needs

            • Our analysts will work directly with you and understand your needs
            • Get data on specified regions or segments, competitor and Vendors
            • Data will be formatted and presented as per your requirements
            • We offer $1000 worth of FREE customization at the time of purchase

            Let us help you make report more suited to your requirements.

            • Get a competitive breakdown as per your niche industry
            • Customize the data with various metrics that meet your business prerequisite
            • Understand Revenue Sources, Customers and many more
            • Details on Market Share
            • These customizations are done in a short amount of time by our analysts and industry experts
            Technavio
            Enquire Before Buying
            17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>